At TDI, we aim to bring powerful drug discovery technologies to researchers across the Tri-Institutional community. We have established productive partnerships with a range of cutting-edge technology-based organizations, including Ablexis, Charles River Labs, ChemPartner, Frontage, Horizon, LakePharma, NY Structural Biology, Schrödinger, Taconic, WuXi AppTec and XTAL, among others. We continue to develop strategic relationships with world-class providers of tools and technologies in both the small molecule and antibody realms.